Articles From: TG Therapeutics Announces Exercise of License Option for Its Novel, Next Generation PI3K-Delta Inhibitor, TGR-1202 to Olivier Danos Joins Biogen Idec as Senior Vice President, Gene Therapy


http://media.marketwire.com/attachments/201311/207012_jpg_IPC_Logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1146333&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Ideal Power Receives Order for Distributed Wind Application investment picks
2014/9/23
Largest U.S. general builder drives efficiency through expanded implementation of Textura payment solution.
Sign-up for Turner Construction Company Launches Company-Wide Rollout of Textura-CPM investment picks
Brings More than 20 Years of Experience in Transportation and Finance VAN BUREN, Ark.
Sign-up for USA Truck Appoints Michael K. Borrows As Chief Financial Officer investment picks
2014/9/23
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G022303-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/22/11G022303/Logo1-1556270228.jpg ATLANTA, GA and WARSAW, POLAND--(Marketwired - September 23, 2014) - Perma-Fix Medical S.A. (WAR: PFM), a subsidiary of Perma-Fix Environmental Services, Inc. (NASDAQ: PESI), and developer of a reliable, cost effective, non-uranium process to produce technetium-99 (Tc-99m), the most widely used medical isotope in the world, today announced that management will present at the upcoming 2nd Global Life Sciences Conference in Warsaw on October 2, 2014 at the trading floor of the Warsaw Stock Exchange, Warsaw, Poland.
Sign-up for Perma-Fix Medical to Present at 2nd Global Life Sciences Conference in Warsaw investment picks
Ophthotech Corporation (Nasdaq:OPHT) today announced that Michael G.
Sign-up for Ophthotech Corporation Names Michael G. Atieh as Executive Vice President and Chief Financial and Business Officer investment picks
FARMINGDALE, N.Y. , Sept.
Sign-up for Misonix Supports Uganda Spine Surgery Mission with Ultrasonic BoneScalpel™ investment picks
ROCHESTER, N.Y., Sept.
Sign-up for Monro Muffler Brake, Inc. to Participate in the TAG 2014 Consumer Conference investment picks
By Andria Cheng, MarketWatch NEW YORK (MarketWatch) -- Investor jitters are in the air ahead of Bed, Bath & Beyond Inc.'s (BBBY) fiscal second quarter earnings release on Tuesday.
Sign-up for UPDATE: What to look for in Bed, Bath & Beyond earnings investment picks
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch)--Carnival Corp.
Sign-up for UPDATE: What to watch for in Carnival earnings investment picks
2014/9/23
The ARRIS E6000™ Converged Edge Router to provide VTR with new levels of bandwidth and efficiency SUWANEE, Ga.
Sign-up for Chile's VTR Selects ARRIS to Enhance High-Speed Broadband Services investment picks
2014/9/23
By Ian Walker LONDON --
Sign-up for UPDATE: Barclays fined $62 million by U.K. regulator investment picks
ANSYS revolutionizes model-based design by combining Modelica models and libraries with VHDL-AMS, embedded software and detailed 3-D multiphysics PITTSBURGH , Sept.
Sign-up for ANSYS Enables Virtual Systems Prototyping investment picks
Accenture (NYSE:ACN) will host a conference call at 8:00 a.m. EDT tomorrow, Wednesday, Sept.
Sign-up for Accenture to Host Conference Call Tomorrow, Wednesday, Sept. 24, to Discuss Fourth-Quarter and Fiscal Year 2014 Results investment picks
NICE is the winner of an ASIS Accolades Award for its Suspect Search solution, which it will showcase for the first time at the event PARAMUS, New Jersey , September 23, 2014 /PRNewswire/ -- NICE Systems (NASDAQ: NICE) today announced that it will demonstrate its newly launched Suspect Search solution at booth #1443 at the ASIS International 60th Annual Seminar and Exhibits.
Sign-up for NICE to Showcase New Video Analytics Search Solution at ASIS investment picks
Polaris Industries Inc. (NYSE:PII) today announced the grand opening of its new manufacturing facility in Opole, Poland.
Sign-up for Polaris Announces Grand Opening of Manufacturing Facility in Poland investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0969141001&sourceType=1 http://www.ccnmatthews.com/logos/20110321-wabco200.jpg BRUSSELS, BELGIUM --
Sign-up for WABCO Notes Further Softening in Global Commercial Vehicle Production; Reaffirms Range of Full Year 2014 Guidance with Performance Now Expected at Lower End investment picks
2014/9/23
The New York Times today introduced “Watching,” a major new feature on the NYTimes.com homepage on desktop and on the mobile website.
Sign-up for The New York Times Launches New Homepage “Watching” Feature investment picks
Emergent BioSolutions Inc. (NYSE:EBS) today announced the initiation of the pivotal non-clinical efficacy study to demonstrate that BioThrax ® (Anthrax Vaccine Adsorbed) manufactured at large scale in the company’s new modern facility, Building 55, is comparable to the BioThrax currently manufactured in its approved facility, Building 12.
Sign-up for Emergent BioSolutions Initiates Final Pivotal Study to Support Licensure of BioThrax at Large Scale investment picks
2014/9/23
DENVER , Sept.
Sign-up for CoBiz Financial Invites You to Join Its Third Quarter 2014 Conference Call investment picks
Best-in-class Voice Communications Solution Targets Enterprise Hands-free Communication ALISO VIEJO, Calif.
Sign-up for Microsemi Introduces ZL38040, the First Timberwolf-based Product with New AcuEdge Acoustic Technology investment picks
PETAH TIKVA, Israel, Sept.
Sign-up for Terabit Wave to Provide Gilat Satcom-On-The-Move Terminals in Myanmar investment picks
2014/9/23
To accelerate its leading position in mobile advertising, Millennial Media (NYSE: MM) today announced it has signed a definitive agreement to acquire Nexage for approximately $107.5 million in cash and stock, subject to certain adjustments.
Sign-up for Millennial Media to Acquire Nexage, a Leading Mobile SSP and Advertising Exchange investment picks
PORTLAND, Ore.
Sign-up for Rentrak Signs TV Ratings Agreement With Viacom 18 Media's IndiaCast investment picks
Biogen Idec (NASDAQ:BIIB) today announced that Olivier Danos, Ph.D., has joined the company as senior vice president, Gene Therapy.
Sign-up for Olivier Danos Joins Biogen Idec as Senior Vice President, Gene Therapy investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: TG Therapeutics Announces Exercise of License Option for Its Novel, Next Generation PI3K-Delta Inhibitor, TGR-1202 to Olivier Danos Joins Biogen Idec as Senior Vice President, Gene Therapy
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent